Rationale and design of two trials assessing efficacy, safety and tolerability of Inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia. (August 2022)

Record Type:
Journal Article
Title:
Rationale and design of two trials assessing efficacy, safety and tolerability of Inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia. (August 2022)
Main Title:
Rationale and design of two trials assessing efficacy, safety and tolerability of Inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia
Authors:
Reijman, M.D.
Schweizer, A.
Peterson, A.L.H.
Bruckert, E.
Stratz, C.
Defesche, J.C.
Hegele, R.A.
Wiegman, A.
Abstract:
Is Part Of:
Atherosclerosis. Volume 355(2022)
Journal:
Atherosclerosis
Issue:
Volume 355(2022)
Issue Display:
Volume 355, Issue 2022 (2022)
Year:
2022
Volume:
355
Issue:
2022
Issue Sort Value:
2022-0355-2022-0000
Page Start:
150
Page End:
Publication Date:
2022-08
Subjects:
Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:
http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.atherosclerosis.2022.06.657 ↗
Languages:
English
ISSNs:
0021-9150
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
23301.xml